These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 5380948)

  • 41. [Metabolism of fibrinogen following administration of brain phospholipids in combination with an antifibrinolytic agent (AMCHA)].
    Cultrera G; Lampugnani P
    Arzneimittelforschung; 1973 Mar; 23(3):445-7. PubMed ID: 4740135
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of fibrinolysis and coagulation on haemostatic plug formation. An experimental study in rabbits.
    Bergqvist D; Arfors KE
    Thromb Res; 1974 Feb; 4(2):345-60. PubMed ID: 4831008
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of para-aminomethylbenzoic acid on the post-irradiation disturbance of haemocoagulation in dogs after whole-body exposure to 600 R.
    Pospísil J; Skala E; Vranovská J; Dienstbier Z
    Strahlentherapie; 1972 Dec; 144(6):728-36. PubMed ID: 4567740
    [No Abstract]   [Full Text] [Related]  

  • 44. [The action of fibrinolysis inhibitors of the omega-aminocarboxylic acid type on the proliferation of in vitro cultured endothelial cells].
    Pilgrim H
    Pharmazie; 1986 Jul; 41(7):519-20. PubMed ID: 3490674
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 47. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.
    Coombey D; Tyler HM
    Thromb Diath Haemorrh; 1972 Apr; 27(2):241-5. PubMed ID: 5049613
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs.
    Pratt HW; Celander DR
    J Am Osteopath Assoc; 1970 Jun; 69(10):1049-50. PubMed ID: 5201432
    [No Abstract]   [Full Text] [Related]  

  • 49. Trans-4-aminomethylcyclohexanecarboxylic acid as a potent antiplasmin agent.
    Shimizu M; Naito T; Okano A; Aoyagi T
    Chem Pharm Bull (Tokyo); 1965 Aug; 13(8):1012-4. PubMed ID: 5867824
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the influence of protease inhibitors and synthetic antifibrinolytic agents on the bleeding time].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):174-8. PubMed ID: 4174655
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative studies on antifibrinolytic agents].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):106-12. PubMed ID: 4173870
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of thrombin infusions upon 131-I-labelled fibrinogen in dogs.
    Nordström S; Zetterqvist E
    Acta Physiol Scand; 1968; 72(1):85-99. PubMed ID: 5301454
    [No Abstract]   [Full Text] [Related]  

  • 53. [Influence of an inhibitor of fibrinolysis on the circulatory system of burned skin].
    Laurentaci G; Oliva V; Ferrarese S
    Boll Soc Ital Biol Sper; 1965 Apr; 41(8):413-4. PubMed ID: 5875562
    [No Abstract]   [Full Text] [Related]  

  • 54. [Endogenous and exogenous fibrinolysis].
    Perlick E; Wilfert K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):28-32. PubMed ID: 4189368
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of fibrinolytics and antifibrinolytics on wound healing. Experimental study].
    Wilde J; Ampt HJ
    Z Exp Chir; 1971; 4(4):241-7. PubMed ID: 5317395
    [No Abstract]   [Full Text] [Related]  

  • 56. [Localized fibrinolysis of the tonsil and antiplasmin compounds].
    Asaga M; Okamoto M; Asaga H; Kimura M
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):462-3. PubMed ID: 5106660
    [No Abstract]   [Full Text] [Related]  

  • 57. [Fibrinolytic inhibitors].
    Nagamatsu A
    Saishin Igaku; 1966 Feb; 21(2):320-5. PubMed ID: 5966316
    [No Abstract]   [Full Text] [Related]  

  • 58. Clearance of infused fibrin.
    Lewis JH; Szeto IL
    Fed Proc; 1965; 24(4):840-5. PubMed ID: 4220570
    [No Abstract]   [Full Text] [Related]  

  • 59. [Increased fibrinolytic activity in thrombocytopenia and its therapeutic modification by PAMBA].
    Thiele G
    Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1296-8. PubMed ID: 5403440
    [No Abstract]   [Full Text] [Related]  

  • 60. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.